J. Rotonda

1.3k total citations
16 papers, 1.1k citations indexed

About

J. Rotonda is a scholar working on Molecular Biology, Oncology and Urology. According to data from OpenAlex, J. Rotonda has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Urology. Recurrent topics in J. Rotonda's work include Signaling Pathways in Disease (4 papers), Peptidase Inhibition and Analysis (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). J. Rotonda is often cited by papers focused on Signaling Pathways in Disease (4 papers), Peptidase Inhibition and Analysis (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). J. Rotonda collaborates with scholars based in United States, Canada and Norway. J. Rotonda's co-authors include Joseph W. Becker, Nancy A. Thornberry, Donald W. Nicholson, Erin P. Peterson, Michel Gallant, Dita Rasper, John P. Vaillancourt, Marc Labelle, Réjean Ruel and Yves Gareau and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and The Journal of Urology.

In The Last Decade

J. Rotonda

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Rotonda United States 13 778 199 180 134 117 16 1.1k
Massimiliano Gaetani Sweden 19 637 0.8× 99 0.5× 268 1.5× 19 0.1× 101 0.9× 50 1.3k
David K. Crockett United States 22 619 0.8× 171 0.9× 137 0.8× 6 0.0× 79 0.7× 49 1.2k
Marta Martínez Spain 16 717 0.9× 262 1.3× 177 1.0× 7 0.1× 83 0.7× 28 1.2k
Volker Badock Germany 14 687 0.9× 124 0.6× 74 0.4× 10 0.1× 115 1.0× 17 909
Shama Kajiji United States 14 372 0.5× 497 2.5× 121 0.7× 7 0.1× 229 2.0× 23 1.1k
Eric B. Springman United States 15 479 0.6× 348 1.7× 74 0.4× 10 0.1× 46 0.4× 25 1.1k
Yanling Wu China 19 934 1.2× 252 1.3× 266 1.5× 6 0.0× 46 0.4× 41 1.4k
Gai Yan United States 9 759 1.0× 124 0.6× 101 0.6× 8 0.1× 34 0.3× 16 943
Hollis R. Williams United States 12 337 0.4× 155 0.8× 146 0.8× 8 0.1× 111 0.9× 15 810
Richard J. Rebello Australia 13 649 0.8× 317 1.6× 120 0.7× 7 0.1× 61 0.5× 18 1.4k

Countries citing papers authored by J. Rotonda

Since Specialization
Citations

This map shows the geographic impact of J. Rotonda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Rotonda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Rotonda more than expected).

Fields of papers citing papers by J. Rotonda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Rotonda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Rotonda. The network helps show where J. Rotonda may publish in the future.

Co-authorship network of co-authors of J. Rotonda

This figure shows the co-authorship network connecting the top 25 collaborators of J. Rotonda. A scholar is included among the top collaborators of J. Rotonda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Rotonda. J. Rotonda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Anderson, Matt S., Teddy Kosoglou, Paul Statkevich, et al.. (2017). No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers. Clinical Pharmacology in Drug Development. 7(2). 143–150. 3 indexed citations
2.
Olsen, Elise A., David A. Whiting, R Savin, et al.. (2012). Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. Journal of the American Academy of Dermatology. 67(3). 379–386. 30 indexed citations
3.
Kaplan, Steven A., Claus G. Roehrborn, John D. McConnell, et al.. (2008). Long-Term Treatment With Finasteride Results in a Clinically Significant Reduction in Total Prostate Volume Compared to Placebo Over the Full Range of Baseline Prostate Sizes in Men Enrolled in the MTOPS Trial. The Journal of Urology. 180(3). 1030–1033. 63 indexed citations
4.
Kaufman, Keith D., J. Rotonda, Arvind Shah, & Alan G. Meehan. (2008). Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).. PubMed. 18(4). 400–6. 44 indexed citations
5.
Kaufman, Keith D., Cynthia J. Girman, Elizabeth Round, et al.. (2008). Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.. PubMed. 18(4). 407–11. 18 indexed citations
6.
7.
Becker, Joseph W., J. Rotonda, S.M. Soisson, et al.. (2004). Reducing the Peptidyl Features of Caspase-3 Inhibitors:  A Structural Analysis. Journal of Medicinal Chemistry. 47(10). 2466–2474. 73 indexed citations
8.
Han, Yongxin, André Giroux, Erich L. Grimm, et al.. (2003). Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(3). 805–808. 23 indexed citations
9.
Rotonda, J., Margarita García‐Calvo, Wayne M. Geissler, et al.. (2001). The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1. Chemistry & Biology. 8(4). 357–368. 67 indexed citations
10.
Becker, Joseph W., J. Rotonda, John G. Cryan, et al.. (1999). 32-Indolyl Ether Derivatives of Ascomycin:  Three-Dimensional Structures of Complexes with FK506-Binding Protein. Journal of Medicinal Chemistry. 42(15). 2798–2804. 11 indexed citations
11.
Rano, Thomas A., Erin P. Peterson, J. Rotonda, et al.. (1997). A combinatorial approach for determining protease specificities: application to interleukin-1β converting enzyme (ICE). Chemistry & Biology. 4(2). 149–155. 216 indexed citations
12.
Rotonda, J., Donald W. Nicholson, Michel Gallant, et al.. (1996). The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Structural Biology. 3(7). 619–625. 356 indexed citations
13.
Rotonda, J. & J.W. Becker. (1996). The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Acta Crystallographica Section A Foundations of Crystallography. 52(a1). C581–C581. 3 indexed citations
14.
Becker, J.W., J. Rotonda, Brian M. McKeever, et al.. (1993). FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. Journal of Biological Chemistry. 268(15). 11335–11339. 55 indexed citations
15.
Rotonda, J., Jonathan J. Burbaum, Hak‐Kim Chan, A I Marcy, & J.W. Becker. (1993). Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis.. Journal of Biological Chemistry. 268(11). 7607–7609. 44 indexed citations
16.
Rotonda, J., Jonathan J. Burbaum, Hak‐Kim Chan, A I Marcy, & J.W. Becker. (1993). Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis.. PubMed. 268(11). 7607–9. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimiliano Gaetani Breakdown of academic impact, for papers by David K. Crockett Breakdown of academic impact, for papers by Marta Martínez Breakdown of academic impact, for papers by Volker Badock Breakdown of academic impact, for papers by Shama Kajiji Breakdown of academic impact, for papers by Eric B. Springman Breakdown of academic impact, for papers by Yanling Wu Breakdown of academic impact, for papers by Gai Yan Breakdown of academic impact, for papers by Hollis R. Williams Breakdown of academic impact, for papers by Richard J. Rebello
Rankless by CCL
2026